[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0102184D0 - New subject-matter - Google Patents

New subject-matter

Info

Publication number
SE0102184D0
SE0102184D0 SE0102184A SE0102184A SE0102184D0 SE 0102184 D0 SE0102184 D0 SE 0102184D0 SE 0102184 A SE0102184 A SE 0102184A SE 0102184 A SE0102184 A SE 0102184A SE 0102184 D0 SE0102184 D0 SE 0102184D0
Authority
SE
Sweden
Prior art keywords
subject matter
new subject
mesotocin
oxytocin
tri
Prior art date
Application number
SE0102184A
Other languages
English (en)
Inventor
Kerstin Uvnaes-Moberg
Thomas Lundeberg
Maria Petersson
Original Assignee
Uvnaes Moberg Kerstin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uvnaes Moberg Kerstin filed Critical Uvnaes Moberg Kerstin
Priority to SE0102184A priority Critical patent/SE0102184D0/sv
Publication of SE0102184D0 publication Critical patent/SE0102184D0/sv
Priority to EP02739051A priority patent/EP1409518B1/en
Priority to PCT/SE2002/001207 priority patent/WO2002102832A1/en
Priority to US10/481,623 priority patent/US7714105B2/en
Priority to DE60224280T priority patent/DE60224280D1/de
Priority to AT02739051T priority patent/ATE382054T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE0102184A 2001-06-19 2001-06-19 New subject-matter SE0102184D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0102184A SE0102184D0 (sv) 2001-06-19 2001-06-19 New subject-matter
EP02739051A EP1409518B1 (en) 2001-06-19 2002-06-19 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
PCT/SE2002/001207 WO2002102832A1 (en) 2001-06-19 2002-06-19 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
US10/481,623 US7714105B2 (en) 2001-06-19 2002-06-19 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
DE60224280T DE60224280D1 (de) 2001-06-19 2002-06-19 Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis
AT02739051T ATE382054T1 (de) 2001-06-19 2002-06-19 Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102184A SE0102184D0 (sv) 2001-06-19 2001-06-19 New subject-matter

Publications (1)

Publication Number Publication Date
SE0102184D0 true SE0102184D0 (sv) 2001-06-19

Family

ID=20284539

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102184A SE0102184D0 (sv) 2001-06-19 2001-06-19 New subject-matter

Country Status (6)

Country Link
US (1) US7714105B2 (sv)
EP (1) EP1409518B1 (sv)
AT (1) ATE382054T1 (sv)
DE (1) DE60224280D1 (sv)
SE (1) SE0102184D0 (sv)
WO (1) WO2002102832A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4654418B2 (ja) * 2004-03-31 2011-03-23 独立行政法人産業技術総合研究所 上皮系細胞増殖促進剤
FR2954167A1 (fr) 2009-09-04 2011-06-24 Centre Nat Rech Scient Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
HUE065385T2 (hu) 2015-01-07 2024-05-28 Tonix Pharma Ltd Magnézium tartalmú oxitocin készítmények és felhasználásuk módszerei
JP6527996B2 (ja) * 2017-09-12 2019-06-12 株式会社 金冠堂 Ｆｇｆ活性に影響を与えるジペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
EP0146113A3 (de) 1983-12-15 1987-08-19 Dieter Aderhold Wirkstoff und therapeutisches Mittel zur Behandlung von Fehlfunktionen des Diencephalon, von Nervenerkrankungen und Erkrankungen der Haut
US5767083A (en) * 1994-05-04 1998-06-16 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
SE9803271D0 (sv) * 1998-09-25 1998-09-25 Kerstin Uvnaes Moberg A drug for well-being

Also Published As

Publication number Publication date
DE60224280D1 (de) 2008-02-07
EP1409518B1 (en) 2007-12-26
EP1409518A1 (en) 2004-04-21
ATE382054T1 (de) 2008-01-15
WO2002102832A1 (en) 2002-12-27
US7714105B2 (en) 2010-05-11
US20040259805A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CY1108547T1 (el) Αναλογα σωματοστατινης
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
SE0301653D0 (sv) Novel compounds
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
CL2008001813A1 (es) Compuestos derivados de quinolin-3-carbonitrilo sustituidos con piperazina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis, inflamacion, cancer entre otras (div. sol. 266-04).
DE60307677D1 (de) Dispergierbare pharmazeutische zusammensetzungen
NO992102L (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
EP1539122A4 (en) PHARMACEUTICAL COMPOSITIONS OF AQUEOUS 2,6-DIISOPROPYLPHENOL
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
SI1622939T1 (sl) Akrivne variante il-18 vezavnega proteina in medicinske uporabe le-tega
DE50113345D1 (de) Arginin-mimetika als faktor xa-inhibitoren
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
PT1290160E (pt) Polipeptideos pellino humanos
SE0102184D0 (sv) New subject-matter
DK1476467T3 (da) IgG3-immunglobulin som beskyttelsesmarkör mod virusinfektionssygdomme og anvendelser deraf
SE0200657D0 (sv) Novel Formulation
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
SE0101220D0 (sv) New use
WO2005035746A3 (en) Medical use of tbk-1 or of inhibitors thereof
DK1626726T3 (da) Anvendelse af lornoxicam eller lornoxicam-analoger
GB0128071D0 (en) Medicament
ITMI20011379A0 (it) Procedimento per la preparazione del divalproato sodico